关键词: disorder disorders dysphoria dysphoric disorder premenstrual syndrome review scoping syndrome treatment

来  源:   DOI:10.1176/appi.focus.23021035   PDF(Pubmed)

Abstract:
Premenstrual dysphoric disorder (PMDD) and premenstrual syndrome (PMS) refer to physical, cognitive, or affective symptoms that arise in the late luteal phase and remit with menses. The present work is a clinically focused scoping review of the last twenty years of research on treatment for these disorders. A search of key terms using the PubMed/Medline, the Cochrane Library, Embase, and Web of Science databases was performed, and 194 studies of adult women met initial inclusion criteria for review. Research studies concerning medications, pharmacological and non-pharmacological complementary and alternative medicine treatments, and surgical interventions with the most available evidence were appraised and summarized. The most high-quality evidence can be found for the use of selective serotonin reuptake inhibitors (SSRIs) and combined oral contraceptives (COCs), with gonadotropin releasing hormone (GnRH) agonists and surgical interventions showing efficacy for refractory cases. While there is some evidence of the efficacy of alternative and complementary medicine treatments such as nutraceuticals, acupuncture, and yoga, variability in quality and methods of studies must be taken into account. Reprinted from Int J Womens Health 2022; 14:1783-1801, with permission from Dove Medical Press Ltd. Copyright © 2022.
摘要:
经前烦躁不安症(PMDD)和经前综合症(PMS)是指身体,认知,或出现在黄体后期并缓解月经的情感症状。目前的工作是对这些疾病治疗的最近二十年研究的临床聚焦范围审查。使用PubMed/Medline搜索关键术语,Cochrane图书馆,Embase,进行了WebofScience数据库,194项成年女性研究符合初始纳入标准进行审查.关于药物的研究,药理学和非药理学补充和替代医学治疗,对现有证据最多的外科干预措施进行了评估和总结.可以找到使用选择性5-羟色胺再摄取抑制剂(SSRIs)和联合口服避孕药(COCs)的最高质量的证据。促性腺激素释放激素(GnRH)激动剂和手术干预对难治性病例有效。虽然有一些证据表明替代和补充药物治疗如营养品的疗效,针灸,还有瑜伽,必须考虑研究质量和方法的可变性。转载自IntJWomensHealth2022;14:1783-1801,经DoveMedicalPressLtd.版权所有©2022。
公众号